# Portfolio

Last updated: 2026-08-05 (intraday risk-reduction routine, ~13:13 ET) —
reconciled against Alpaca, no discrepancy this run (single MSFT position,
matches record). Risk-reduction-only scope; no new positions permitted, no
sell triggers fired, no orders placed.

**Alpaca is the source of truth.** This file is a human-readable mirror with
the reasoning attached, which the broker does not store. If they disagree,
trust Alpaca, fix this file, and log why they drifted.

## Snapshot

| Field | Value |
|-------|-------|
| Mode | PAPER |
| Equity | $100,069.63 |
| Cash | $99,000.00 |
| Open positions | 1 |
| New positions this week | 0 (per Alpaca `new_positions_this_week`) |

## Holdings

### MSFT — 1.05% of equity
- **Entry:** 2026-07-31, $456.70 avg, $1,000 notional (2.189599299 sh)
- **Thesis:** Azure/cloud revenue growth is accelerating (40% -> 43% YoY,
  FQ3 -> FQ4 FY26) on real reported numbers, not capex narrative; EPS
  growth (FY26 GAAP diluted EPS $17.95) is outrunning the post-earnings
  price move, so the ~25.2x trailing P/E is near the bottom of MSFT's own
  5-year range despite the stock being up double digits post-print.
- **Invalidation:** Azure YoY growth decelerates back below ~35% in the
  FQ1 FY27 print, commercial RPO growth reverses meaningfully, or capex
  guidance is cut in a way that reads as AI-monetization doubt rather than
  discipline.
- **Catalyst:** already happened (FY26 Q4 earnings, reported 2026-07-29);
  next checkpoint is the FQ1 FY27 print.
- **Stop:** 10% trailing stop live, order id
  `cee441de-48ae-4e48-9cc2-d6482a4c3b0a`, covers 2 of 2.19 whole shares
  (Alpaca does not accept trailing stops on the fractional remainder).
  Confirmed still open as of 2026-08-05 ~13:13 ET check: status `new`, hwm
  $499.34, stop price $449.406 — unchanged since 2026-08-04.
- **Status:** on track — up 6.96% unrealized ($488.50 vs $456.70 entry,
  Alpaca's own position mark) as of 2026-08-05 intraday check, a small
  pullback from the ~8.4-8.7% reads earlier this week, still well inside
  normal noise. Latest thesis-invalidation check (2026-08-05 ~13:13 ET,
  Perplexity restricted to primary sources) found no new 8-K, no new Azure
  guidance, no commercial RPO update, no capex commentary since the
  2026-07-29 FY26 Q4 print — only new item was an unrelated Form 144
  (insider proposed-sale notice, June 2026) for Takeshi Numoto. Thesis
  unchanged and intact. Well inside the -7%/-15% sell triggers and the
  5%-of-equity trim threshold (~1.07% of equity).

Format for each position, one block:

### TICKER — 0.0% of equity
- **Entry:** date, avg price, size
- **Thesis:** one sentence, falsifiable
- **Invalidation:** the specific thing that would make this wrong
- **Catalyst:** what and roughly when
- **Stop:** trailing % if set
- **Status:** on track / watching / trimming

## Benchmark

| Date | Portfolio | SPY | Delta |
|------|-----------|-----|-------|
| 2026-07-30 | 0.00% | +1.65% | -1.65% |
| 2026-07-31 | +0.02% | +0.70% | -0.68% |
| 2026-08-03 | +0.05% | +1.46% | -1.41% |
| 2026-08-04 | +0.02% | +1.77% | -1.75% |

Since-inception delta (2026-07-29 close baseline, when the account was first
funded at $100,000 with 0 positions, SPY `prev_close` 729.57): portfolio
+0.08% ($100,000 → $100,083.15), SPY +5.69% (729.57 → 771.11 per
`alpaca.py quote SPY` at 2026-08-04 close), delta **-5.61%**. The one MSFT
position (bought 2026-07-31) is up nicely on its own terms (+8.32% since
entry), but the account has been ~99% cash through a period where SPY ran up
meaningfully — the delta is still a cash-drag story, not a stock-picking
loss: the one position taken is beating the benchmark by a wide margin, the
account just hasn't deployed enough capital yet to matter. That said, the
gap is now widening every day (-3.79% on 08-03 to -5.61% today) purely
because SPY keeps running while the account sits ~99% cash — worth noting
plainly rather than repeating "cash drag, not stock-picking" as if the size
of the gap doesn't matter. Not a reason to force new buys —
`strategy.md`'s buy criteria are still the gate, not the scoreboard.

---

## Daily-close entry — 2026-08-03

Markets closed. Per this routine's scope, no orders were placed or
evaluated — reconciliation and record-keeping only.

**Reconciliation:** `alpaca.py account` and `positions` checked against this
file. Equity $100,066.33, cash $99,000.00, one open position (MSFT, qty
2.189599299, avg entry $456.70) — all match what was on record from the
day's earlier routines. No discrepancy, nothing to log in `lessons.md`.

**Benchmark:** today's portfolio return +0.05% vs SPY +1.46% (SPY
`prev_close` $746.79 → `last` $757.72), delta -1.41%. Since inception,
portfolio +0.07% vs SPY +3.86%, delta -3.79%. See table and discussion
above — this remains a cash-drag story (account is ~99% cash by design,
single 1%-sized MSFT position), not evidence the stock-picking itself is
off; the one position held is comfortably ahead of the benchmark on its own
entry.

**Trades:** none placed, none rejected — market was closed for this
routine's entire scope.

**Positions >5% underwater from entry:** none. MSFT is up 6.64%, nowhere
near a sell trigger.

**Watching tomorrow:** nothing new — MSFT thesis unchanged (Azure YoY
growth trend, next checkpoint the FQ1 FY27 print, still months out). No
watchlist candidates open; sourcing a new one is out of scope for this
routine.

---

## Daily-close entry — 2026-08-04

Markets closed. Per this routine's scope, no orders were placed or
evaluated — reconciliation and record-keeping only.

**Reconciliation:** `alpaca.py account` and `positions` checked against this
file. Equity $100,083.15, cash $99,000.00, one open position (MSFT, qty
2.189599299, avg entry $456.70, current $494.68) — all match what was on
record from the day's earlier routines and this file. No discrepancy,
nothing to log in `lessons.md`. Trailing stop (`cee441de-48ae-4e48-9cc2-d6482a4c3b0a`)
confirmed still live: status `new`, hwm $499.34, stop price $449.406,
covering 2 of 2.19 whole shares.

**Benchmark:** today's portfolio return +0.02% vs SPY +1.77% (SPY
`prev_close` $757.72 → `last` $771.11), delta -1.75%. Since inception,
portfolio +0.08% vs SPY +5.69%, delta -5.61%. See table and discussion
above — this remains a cash-drag story (account is ~99% cash by design,
single ~1%-sized MSFT position), not evidence the stock-picking itself is
off; the one position held is comfortably ahead of the benchmark on its own
entry (+8.32% vs entry). The since-inception delta is widening daily
(-3.79% on 08-03, -5.61% today) purely from SPY's run and the account's
cash weight — flagged plainly rather than smoothed over, though it is not,
on its own, a reason to force a buy that doesn't clear `strategy.md`'s
criteria.

**Trades:** none placed, none rejected — market was closed for this
routine's entire scope.

**Positions >5% underwater from entry:** none. MSFT is up 8.32%, nowhere
near a sell trigger.

**Watching tomorrow:** nothing new — MSFT thesis unchanged (Azure YoY
growth trend, next checkpoint the FQ1 FY27 print, still months out). No
watchlist candidates open; sourcing a new one is out of scope for this
routine. Worth a future pre-market/research run actively sourcing a second
candidate given the account is still ~99% cash six trading days in — not
urgent enough to justify anything today.
